e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Systemic effects of OSA
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exhaled breath markers in patients with obstructive sleep apnea (OSA): baseline assessment and the impact of treatment with nasal continuous positive airway pressure
M. Agrafiotis, M. Petrosyan, E. Perraki, N. Rovina, D. Simoes, E. Dima, E. Vagiakis, C. Roussos, C. Gratziou (Athens, Greece)
Source:
Annual Congress 2005 - Systemic effects of OSA
Session:
Systemic effects of OSA
Session type:
Thematic Poster Session
Number:
2307
Disease area:
Airway diseases, Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Agrafiotis, M. Petrosyan, E. Perraki, N. Rovina, D. Simoes, E. Dima, E. Vagiakis, C. Roussos, C. Gratziou (Athens, Greece). Exhaled breath markers in patients with obstructive sleep apnea (OSA): baseline assessment and the impact of treatment with nasal continuous positive airway pressure. Eur Respir J 2005; 26: Suppl. 49, 2307
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Evaluation of continuous positive airway pressure compliance in a group of obstructive sleep apnea patients
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012
Effects of nasal continuous positive airway pressure treatment on C-reactive protein in patients with obstructive sleep apnea
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009
Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke
Source: Eur Respir J 2001; 18: 623-629
Year: 2001
Index for comfort of patients with obstructive sleep apnea on continuous positive airway pressure therapy
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008
Liver function following continuous positive airway pressure therapy in obstructive sleep apnea patients
Source: International Congress 2017 – CPAP therapy
Year: 2017
Bronchial reactivity in patients with obstructive sleep apnea syndrome treated with continuous positive airway pressure
Source: Eur Respir J 2005; 26: Suppl. 49, 569s
Year: 2005
Factors influencing airway inflammation measured by exhaled NO levels in a population with obstructive sleep apnea syndrome (OSA)
Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea
Year: 2010
Influence of nasal obstruction (NO) on obstructive sleep apnea (OSA) severity and continuous positive airway pressure (CPAP) adaptation problems
Source: Annual Congress 2010 - The upper airway and oral appliances
Year: 2010
The influence of short-term therapy of continous positive airway pressure (CPAP) on exhaled nitric oxide concentration (FE
NO
) in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 357s
Year: 2005
Impact of CPAP on asthmatic patients with obstructive sleep apnoea
Source: Eur Respir J 2007; 29: 307-311
Year: 2007
Humidified nasal continuous positive airway pressure in obstructive sleep apnoea
Source: Eur Respir J 2003; 22: 258-262
Year: 2003
Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005
Continuous positive airway pressure in patients with obstructive sleep apnea: Age-dependent adherence
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
Falls in blood pressure in patients with obstructive sleep apnea syndrome after long-term nasal continuous positive airway pressure treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 38s
Year: 2005
Long-term continuous positive airway pressure compliance in females with obstructive sleep apnoea
Source: Eur Respir J 2013; 42: 1255-1262
Year: 2013
Impact of humidification on compliance and side effects in obstructive sleep apnea (OSA) patients under auto continuous positive airway pressure (ACPAP) therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 409s
Year: 2006
Is the daily duration of nasal CPAP ventilation the main determinant of improvement of blood gases in OSAS (obstructive sleep apnoea syndrome) patients?
Source: Eur Respir J 2001; 18: Suppl. 33, 390s
Year: 2001
Erratic adherence to continuous positive airway pressure for obstructive sleep apnea
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018
Titration of continuous positive airway pressure in Chinese patients with obstructive sleep apnea
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012
Adherence to continuous positive airway pressure in women with obstructive sleep apnoea
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept